Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP.

Barker DF, Denison JC, Atkin CL, Gregory MC.

Am J Med Genet. 2001 Jan 15;98(2):148-60.

PMID:
11223851
2.

Expression of mRNA for type IV collagen alpha1, alpha5 and alpha6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome.

Sasaki S, Zhou B, Fan WW, Kim Y, Barker DF, Denison JC, Atkin CL, Gregory MC, Zhou J, Segal Y, Sado Y, Ninomiya Y, Michael AF, Kashtan CE.

Matrix Biol. 1998 Aug;17(4):279-91.

PMID:
9749944
3.

Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Cole BC, Sawitzke AD, Ahmed EA, Atkin CL, David CS.

Infect Immun. 1997 Oct;65(10):4190-8. Erratum in: Infect Immun 1998 May;66(5):2399.

4.

Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q.

Barker DF, Denison JC, Atkin CL, Gregory MC.

Hum Genet. 1997 May;99(5):681-4.

PMID:
9150741
5.

A mutation causing Alport syndrome with tardive hearing loss is common in the western United States.

Barker DF, Pruchno CJ, Jiang X, Atkin CL, Stone EM, Denison JC, Fain PR, Gregory MC.

Am J Hum Genet. 1996 Jun;58(6):1157-65.

6.

Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome.

Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Grönhagen-Riska C, Neumann HP, Trembath R, Tryggvason K.

J Am Soc Nephrol. 1996 May;7(5):702-9.

7.

The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens.

Cole BC, Knudtson KL, Oliphant A, Sawitzke AD, Pole A, Manohar M, Benson LS, Ahmed E, Atkin CL.

J Exp Med. 1996 Mar 1;183(3):1105-10.

8.

Application of linked markers for genetic diagnosis of Alport syndrome.

Barker DF, Atkin CL, Gregory MC, Fain PR.

Contrib Nephrol. 1996;117:29-45. Review. No abstract available.

PMID:
8801047
9.

Alport syndrome--clinical phenotypes, incidence, and pathology.

Gregory MC, Terreros DA, Barker DF, Fain PN, Denison JC, Atkin CL.

Contrib Nephrol. 1996;117:1-28. Review. No abstract available.

PMID:
8801040
10.

Alport syndrome: clinical update.

Wester DC, Atkin CL, Gregory MC.

J Am Acad Audiol. 1995 Jan;6(1):73-9. Review.

PMID:
7696680
11.
12.

Immunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM.

Cole BC, Ahmed E, Araneo BA, Shelby J, Kamerath C, Wei S, McCall S, Atkin CL.

Clin Infect Dis. 1993 Aug;17 Suppl 1:S163-9.

PMID:
8399909
13.

High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: definition and use of flanking polymorphic markers.

Barker DF, Fain PR, Goldgar DE, Dietz-Band JN, Turco AE, Kashtan CE, Gregory MC, Tryggvason K, Skolnick MH, Atkin CL.

Hum Genet. 1991 Dec;88(2):189-94.

PMID:
1684566
14.

The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen.

Cole BC, Atkin CL.

Immunol Today. 1991 Aug;12(8):271-6. Review.

PMID:
1910449
15.

Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome.

Zhou J, Barker DF, Hostikka SL, Gregory MC, Atkin CL, Tryggvason K.

Genomics. 1991 Jan;9(1):10-8.

PMID:
1672282
16.

Identification of mutations in the COL4A5 collagen gene in Alport syndrome.

Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K.

Science. 1990 Jun 8;248(4960):1224-7.

PMID:
2349482
17.

Identification of variant Alport phenotypes using an Alport-specific antibody probe.

Kashtan CE, Atkin CL, Gregory MC, Michael AF.

Kidney Int. 1989 Oct;36(4):669-74.

18.

Mapping of Alport syndrome to the long arm of the X chromosome.

Atkin CL, Hasstedt SJ, Menlove L, Cannon L, Kirschner N, Schwartz C, Nguyen K, Skolnick M.

Am J Hum Genet. 1988 Feb;42(2):249-55.

19.
20.

Genetic heterogeneity among kindreds with Alport syndrome.

Hasstedt SJ, Atkin CL, San Juan AC Jr.

Am J Hum Genet. 1986 Jun;38(6):940-53.

21.
22.

Distinct metal-binding configurations in metallothionein.

Nielson KB, Atkin CL, Winge DR.

J Biol Chem. 1985 May 10;260(9):5342-50.

23.

X-linked inheritance of Alport syndrome: family P revisited.

Hasstedt SJ, Atkin CL.

Am J Hum Genet. 1983 Nov;35(6):1241-51.

24.
25.

Abnormal neutrophil myeloperoxidase from a patient with chronic myelocytic leukemia.

Atkin CL, Andersen MR, Eyre HJ.

Arch Biochem Biophys. 1982 Mar;214(1):284-92. No abstract available.

PMID:
6282222
26.

Intact form of myeloperoxidase from normal human neutrophils.

Andersen MR, Atkin CL, Eyre HJ.

Arch Biochem Biophys. 1982 Mar;214(1):273-83. No abstract available.

PMID:
6282221
27.

Hereditary myeloperoxidase deficiency.

Kitahara M, Eyre HJ, Simonian Y, Atkin CL, Hasstedt SJ.

Blood. 1981 May;57(5):888-93.

28.

Tissue copper concentrations of patients with Menke's kinky hair disease.

Williams DM, Atkin CL.

Am J Dis Child. 1981 Apr;135(4):375-6. No abstract available.

PMID:
7211802
29.

Early pathologic features of hereditary nephritis: a clinicopathologic correlation.

O'Neill WM Jr, Mennemeyer RP, Bloomer HA, Atkin CL.

Pathol Res Pract. 1980;168(1-3):146-62.

PMID:
7001412
30.

Failure of human milk therapy in Menkes' kinky hair disease.

Williams DM, Atkin CL, Seay AR, Bray PF.

Am J Dis Child. 1979 Feb;133(2):218-9. No abstract available.

PMID:
581719
31.

Hereditary nephritis: a re-examination of its clinical and genetic features.

O'Neill WM Jr, Atkin CL, Bloomer HA.

Ann Intern Med. 1978 Feb;88(2):176-82.

PMID:
626446
32.

Evidence for an iron carrier substance in copper-deficient mitochondria.

Williams DM, Barbuto AJ, Atkin CL, Lee GR.

Prog Clin Biol Res. 1978;21:539-49. No abstract available.

PMID:
662905
33.

Menkes' Kinky hair syndrome: studies of copper metabolism and long term copper therapy.

Williams DM, Atkin CL, Frens DB, Bray PF.

Pediatr Res. 1977 Jul;11(7):823-6.

PMID:
876703
34.

Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme.

Atkin CL, Thelander L, Reichard P, Lang G.

J Biol Chem. 1973 Nov 10;248(21):7464-72. No abstract available.

35.

Leaf infections: siderochromes (natural polyhydroamates) mimic the "green island" effect.

Atkin CL, Neilands JB.

Science. 1972 Apr 21;176(4032):300-2.

PMID:
17791918
37.

Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization.

Atkin CL, Neilands JB.

Biochemistry. 1968 Oct;7(10):3734-9. No abstract available.

PMID:
4971459
38.

Chromatographic separation of tertiary nitrogen compounds photodynamic dye precursors.

Atkin CL, Parry EP, Hern DH.

Anal Chem. 1967 May;39(6):672-3. No abstract available.

PMID:
6046001

Supplemental Content

Loading ...
Support Center